Literature DB >> 21502763

High hepatitis B virus DNA level in serum before liver transplantation increases the risk of hepatocellular carcinoma recurrence.

Min-ru Li1, Gui-hua Chen, Chang-jie Cai, Guo-ying Wang, Hui Zhao.   

Abstract

AIM: To analyze the relationship between hepatitis B virus (HBV) and hepatocellular carcinoma (HCC) recurrence in orthotopic liver transplantation (OLT) patients.
METHODS: 340 HBV patients with OLT were included in the study; among them were 148 patients with HBV-associated HCC.
RESULTS: HCC recurrence rates at 1, 3 and 5 years were 21, 29, and 46%, respectively. Exceeding Milan criteria (hazard ratio, HR = 12.35; 95% confidence interval, CI, 2.80-54.49; p = 0.001), HBV DNA level >5 log(10) copies/ml before transplant (HR = 2.45; 95% CI 1.10-5.45; p = 0.03) and HBV recurrence (HR = 2.27; 95% CI 1.10-4.75; p = 0.03) were significant independent predictors of HCC recurrence. HBV DNA >5 log(10) copies/ml before transplant (HR = 8.65; 95% CI 3.40-21.98; p < 0.001) and concomitance with HCC (HR = 2.79; 95% CI 1.33-5.87; p = 0.007) were predictors of HBV recurrence. Further stratified analysis showed that HBV recurrence was more prevalent in the HCC recurrence group (HR = 4.58; 95% CI 1.88-11.12; p = 0.001).
CONCLUSIONS: There is a close relationship between HBV and HCC recurrence after transplant. High HBV DNA levels before transplant are associated with HCC recurrence after transplant.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21502763     DOI: 10.1159/000324197

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  11 in total

Review 1.  Hepatitis B viral load affects prognosis of hepatocellular carcinoma.

Authors:  Su Jong Yu; Yoon Jun Kim
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

2.  Correlation of HBV DNA and Hepatitis B Surface Antigen Levels With Tumor Response, Liver Function and Immunological Indicators in Liver Cancer Patients With HBV Infection Undergoing PD-1 Inhibition Combinational Therapy.

Authors:  Shida Pan; Yingying Yu; Siyu Wang; Bo Tu; Yingjuan Shen; Qin Qiu; Xiaomeng Liu; Nan Su; Yanmei Zuo; Junqing Luan; Ji Yuan Zhang; Ming Shi; Fanping Meng; Fu-Sheng Wang
Journal:  Front Immunol       Date:  2022-05-25       Impact factor: 8.786

3.  Survival in liver transplant recipients with hepatitis B- or hepatitis C-associated hepatocellular carcinoma: the Chinese experience from 1999 to 2010.

Authors:  Zhenhua Hu; Jie Zhou; Haibo Wang; Min Zhang; Shaogang Li; Yuzhou Huang; Jian Wu; Zhiwei Li; Lin Zhou; Shusen Zheng
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

Review 4.  Impact of non-oncological factors on tumor recurrence after liver transplantation in hepatocellular carcinoma patients.

Authors:  Xiang-Qian Gu; Wei-Ping Zheng; Da-Hong Teng; Ji-San Sun; Hong Zheng
Journal:  World J Gastroenterol       Date:  2016-03-07       Impact factor: 5.742

5.  Donor interleukin 6 gene polymorphisms predict the recurrence of hepatocellular carcinoma after liver transplantation.

Authors:  Dawei Chen; Shuanghai Liu; Sheng Chen; Zhaowen Wang; Zehua Wu; Kai Ma; Junwei Fan; Zhihai Peng
Journal:  Int J Clin Oncol       Date:  2016-07-01       Impact factor: 3.402

6.  PARP-1 promotes tumor recurrence after warm ischemic liver graft transplantation via neutrophil recruitment and polarization.

Authors:  Shuai Wang; Fa-Ji Yang; Xun Wang; Yuan Zhou; Bo Dai; Bing Han; Hu-Cheng Ma; Yi-Tao Ding; Xiao-Lei Shi
Journal:  Oncotarget       Date:  2017-10-04

Review 7.  Compliance with ethical standards in the reporting of donor sources and ethics review in peer-reviewed publications involving organ transplantation in China: a scoping review.

Authors:  Wendy Rogers; Matthew P Robertson; Angela Ballantyne; Brette Blakely; Ruby Catsanos; Robyn Clay-Williams; Maria Fiatarone Singh
Journal:  BMJ Open       Date:  2019-02-05       Impact factor: 2.692

8.  Viral Load Pattern Among Hepatitis B Surface Antigen-positive Patients: Laboratory Perspective and Implications for Therapy.

Authors:  K C Iregbu; P I Nwajiobi-Princewill
Journal:  Ann Med Health Sci Res       Date:  2016 Mar-Apr

9.  The contribution of serum hepatitis B virus load in the carcinogenesis and prognosis of hepatocellular carcinoma: evidence from two meta-analyses.

Authors:  Xueqin Chen; Fan Wu; Yanmei Liu; Jiao Lou; Beibei Zhu; Li Zou; Wei Chen; Jing Gong; Ying Wang; Rong Zhong
Journal:  Oncotarget       Date:  2016-08-02

10.  The Matching Status Between Donor and Recipient Hepatitis B Seroepidemiology Makes a Difference in Liver Transplantation for Hepatocellular Carcinoma.

Authors:  Di Lu; Fan Yang; Jianyong Zhuo; Modan Yang; Zuyuan Lin; Pingbo Jin; Xuechun Cai; Beini Cen; Jianguo Wang; Xuyong Wei; Shusen Zheng; Xiao Xu
Journal:  Clin Transl Gastroenterol       Date:  2020-05       Impact factor: 4.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.